Join Director of Business Development, Meytal Waiss, for a Lunch n Learn presentation on June 27th at the PA Biotechnology Center in Doylestown, PA, supported by the Baruch S. Blumberg Institute. Come hear Meytal provide insight into the non-dilutive funding landscape with an emphasis on the NIH, DOD, and BARDA, as she describes the various […]
Congratulations to Ms. Dawn Blessing, VP of Corporate Development at Audentes Therapeutics, on her winning a free bottle of Grant’s whisky after visiting FreeMind’s booth at BIO International last week!
Every year, US-based non-dilutive sources of funding award billions of dollars towards pre-clinical stage research in the Life Sciences. Funding is available for pre-clinical research across scientific fields including Infectious Diseases, Oncology, Neurosciences and many more. These funds come from Institutes within the NIH, such as NIAID, NCI, NINDS, the NSF, the DoD, and private […]
June’s going to be a busy month and we’re heading to BIO International 2016 to kick it off right! Set up a time via the partnering system or email Irina (irina@freemindconsultants.com) to schedule a 1×1 meeting with: * Ram May-Ron, Managing Partner * Ayal Ronen, Vice President * Inna Grodzovski, Senior Analyst * Jonathan Adalist, […]
FreeMind is pleased to announce its sponsorship and invite you to attend New York Venture Summit presented by youngStartup Ventures. **Special discount** Use discount code “FREEMINDVIP” and receive 10% off the “Early Bird” rates! New York Venture Summit Where Innovation Meets Capital July 20 & 21, 2016 | Crowne Plaza | New York City Friends, Come meet, interact and […]
The Congressionally Directed Medical Research Programs (CDMRP), are supported by funds allocated by Congress for biomedical research in response to the needs of the American people and military. With a FY2016 budget of over $800 million, these funds will go towards supporting R&D efforts in various stages of development. Some research areas covered include Breast […]
Purpose: To solicit research applications for milestone-driven projects focused on preclinical development of lead candidate countermeasures (therapeutics, vaccines and related technologies, or diagnostics) against select NIAID Emerging Infectious Diseases/Pathogens. Application Due Date: October 3, 2016 Budget: Direct costs of up to $750,000 per year may be requested. Applicants may also request up to an additional $300,000 in […]
Purpose: NSF’s SBIR and STTR programs provide non-dilutive funds for early-stage research and development (R&D) at small businesses. This R&D should be based on innovative, transformational technology with potential for substantial commercial and/or societal benefits. The programs invite proposals from small businesses across a broad range of science and engineering disciplines. For the STTR program, […]
Every year, US-based non-dilutive sources of funding award billions of dollars towards clinical stage research in the Life Sciences. Funding is available for clinical stage funding across scientific fields including Infectious Diseases, Neurosciences, Cardiovascular, and many more. These funds come from multiple Institutes within the NIH, such as NIAID, NIAMS, NIDDK, from BARDA, and from […]
SBIR/STTR awards account for over $780,000,000 awarded per year by NIH alone. These are excellent sources of funding aimed at promoting R&D activities of US-based small businesses as well as collaborations with Academics. SBIR/STTRs differ from traditional NIH mechanisms in that they are highly product driven and ultimately are seeking commercialization of novel therapies, diagnostics, […]